co.don AG Ár/Könyv
Mi az co.don AG Ár/Könyv?
A Ár/Könyv az co.don AG - 2.82
Mi a Ár/Könyv meghatározása?
Az ár-könyv arány aránya a vállalat részvényértéke és az egy részvényre jutó könyv szerinti érték arányát jelenti.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Ár/Könyv a Health Care szektor a XETRA-on cégekben a co.don AG -hoz képest
Mit csinál co.don AG?
co.don AG engages in cell cultivation for the regenerative treatment of articular cartilage and spinal disc defects worldwide. The company develops, produces, and markets autologous cell therapies for the minimally invasive repair of cartilage damage to knee joints following traumatic or degenerative defects. Its therapies include matrix-associated autologous cartilage transplantation, a biological therapy for the treatment of damaged articular cartilage with the body's own cells; and autologous chondrocyte transplantation for the regeneration of biomechanical load-bearing and pressure-resistant cartilage tissue. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.
ár/könyv -hoz hasonló cégek co.don AG
- Knoll Inc nak Ár/Könyv 2.82 van
- Lifestyle International nak Ár/Könyv 2.82 van
- Clinigen Plc nak Ár/Könyv 2.82 van
- Khadim India nak Ár/Könyv 2.82 van
- ECA Marcellus Trust I nak Ár/Könyv 2.82 van
- Huadian Fuxin nak Ár/Könyv 2.82 van
- co.don AG nak Ár/Könyv 2.82 van
- PlayAGS Inc nak Ár/Könyv 2.82 van
- Lodestar Minerals nak Ár/Könyv 2.82 van
- Evergreen Gaming nak Ár/Könyv 2.82 van
- BelaraRox Ltd nak Ár/Könyv 2.82 van
- WISeKey International AG nak Ár/Könyv 2.82 van
- NEXON Co nak Ár/Könyv 2.82 van